In contrast, NR1H3 upregulation activates hypoxia-induced EMT, reduces the survival rate of GAC patients [75], and promotes the metastasis of renal cell carcinoma by regulating NOD-, LRR-, and pyrin domain-containing protein 3 inflammasomes [76]. Here, NR1H3 is linked to renal cell carcinoma.